ANI Fixed Asset Turnover from 2010 to 2024
| ANIP Stock | USD 63.44 1.46 2.25% |
Fixed Asset Turnover | First Reported 2010-12-31 | Previous Quarter 10.91687036 | Current Value 10.16 | Quarterly Volatility 4.04384333 |
Check ANI Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ANI Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 62.8 M, Interest Expense of 28.9 M or Selling General Administrative of 157.9 M, as well as many indicators such as Price To Sales Ratio of 1.94, Dividend Yield of 0.0012 or PTB Ratio of 2.18. ANI financial statements analysis is a perfect complement when working with ANI Pharmaceuticals Valuation or Volatility modules.
ANI | Fixed Asset Turnover |
Latest ANI Pharmaceuticals' Fixed Asset Turnover Growth Pattern
Below is the plot of the Fixed Asset Turnover of ANI Pharmaceuticals over the last few years. It is ANI Pharmaceuticals' Fixed Asset Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ANI Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Fixed Asset Turnover | 10 Years Trend |
|
Fixed Asset Turnover |
| Timeline |
ANI Fixed Asset Turnover Regression Statistics
| Arithmetic Mean | 7.39 | |
| Geometric Mean | 5.21 | |
| Coefficient Of Variation | 54.69 | |
| Mean Deviation | 3.32 | |
| Median | 7.32 | |
| Standard Deviation | 4.04 | |
| Sample Variance | 16.35 | |
| Range | 13.5967 | |
| R-Value | 0.22 | |
| Mean Square Error | 16.79 | |
| R-Squared | 0.05 | |
| Significance | 0.44 | |
| Slope | 0.20 | |
| Total Sum of Squares | 228.94 |
ANI Fixed Asset Turnover History
About ANI Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include ANI Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. ANI Pharmaceuticals investors use historical funamental indicators, such as ANI Pharmaceuticals's Fixed Asset Turnover, to determine how well the company is positioned to perform in the future. Although ANI Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in ANI Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ANI Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ANI Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ANI Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Fixed Asset Turnover | 10.92 | 10.16 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for ANI Stock Analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.